Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns
At Advantage Living Center in Roseville, Michigan, Janelle prepares medication for a resident Photograph by Ali Lapetina
Letter |
14 April 2021

Letter from civil society organisations to US President Biden on TRIPS Waiver for COVID-19 medical tools

COVID-19
COVID19_Letter_TRIPSWaiverSignOnLetter_ENG_022621
Photograph by Ali Lapetina

Read, watch, share

The MSF treatment centre for COVID-19 patients at the Amirou Boubacar Diallo National Hospital in Niamey, Niger, has 50 beds, with the potential to accommodate up to 100 beds in case of a peak in patient numbers. The semi-permanent structure is completely autonomous to treat patients and limit the risk of transmission to the neighbouring hospital.
Letter
Letter |
18 April 2020
COVID-19

Letter to Trade Ministries and WTO: Stop all trade and investment treaty negotiations during the COVID-19 outbreak

Press release |
16 April 2020
COVID-19
United Kingdom

International organisations call on UK government to prevent Big Pharma profiteering from COVID-19

Letter
Letter |
15 April 2020
COVID-19
United Kingdom

A letter from civil society to the UK government: Impose access conditions for public funding in COVID-19 research

MSF Actions On Covid-19 Pandemic
Press release
Press release |
10 April 2020
COVID-19

MSF response on COVID-19 drugs pricing study by Andrew Hill et al.

ip_germany_patentoppositionprotest_peter_bauza_2018_msf243478_3800px
Letter
Letter |
09 April 2020
COVID-19

Letter to governments to revoke WTO ‘opt-out’ on compulsory licences

No monopolies - Acccess to COVID19 treatment/Brazil
Video
Video |
06 April 2020
COVID-19

No monopolies - Access to COVID-19 treatment

MSF donated 3.5 tonnes of personal protective equipment to health workers at the Wuhan Jinyintan Hospital in Hubei province.
Blog
Blog |
01 April 2020
COVID-19

A coronavirus vaccine must be affordable and accessible to all

MSF teams are loading medical equipment including inflatable hospital in Merignac airport on 21 March 2020 to be sent to Ispahan, Iran to respond to the coronavirus pandemic.
Feature story
Feature story |
01 April 2020
COVID-19
Iran (Islamic Republic of)

MSF response to coronavirus disease COVID-19 - Iran

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury